DJIA 17,440.59 -127.94 -0.73%
NASDAQ 5,039.78 -48.85 -0.96%
S&P 500 2,067.64 -12.01 -0.58%
market minute promo

Novavax, Inc. (NASDAQ: NVAX)

11.62 -0.17 (-1.44%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

NVAX $11.62 -1.44%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $11.75
Previous Close $11.79
Daily Range $11.08 - $11.75
52-Week Range $3.92 - $13.12
Market Cap $3.1B
P/E Ratio -29.48
Dividend (Yield) $0.00 (0.0%)
Volume 4,399,867
Average Daily Volume 4,346,639
Current FY EPS -$0.41




Drug Makers

Novavax, Inc. (NVAX) Description

A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases. Website:

News & Commentary

The Single Greatest Mistake You Can Make When Investing in Biotech

Investing in biotech may look easy, but make this mistake and it could wind up costing you dearly.

Use Options For a Chance To Buy NVAX at a 49% Discount

First Week of September 18th Options Trading For Novavax (NVAX)

Does Novavax Have the Answer for Ebola in New Trial?

Stocks Hitting 52-Week Highs

Morning Market Gainers

Novavax (NVAX) Flagged As Strong On High Volume

Novavax (NVAX) Looks Good: Stock Moves 11% Higher - Tale of the Tape

'Mad Money' Lightning Round: Sell, Sell, Sell Dillard's, It's Overdone

Why Novavax Shares Rocketed Higher By Nearly 25% in June

Novavax shares find their stride in June due to increasing global fears regarding a specific infectious disease. Can Novavax shares head even higher?

See More NVAX News...

NVAX's Top Competitors

NVAX $11.62 (-1.44%)
Current stock: NVAX
AMGN $165.54 (4.38%)
Current stock: AMGN
GILD $110.54 (-2.03%)
Current stock: GILD
BIIB $309.43 (3.13%)
Current stock: BIIB